Konstantin Matentzoglu
Directeur/Bestuurslid bij Polpharma Biologics Group BV
Profiel
Konstantin Matentzoglu is a Member-Supervisory Board at Polpharma Biologics Group BV.
He previously worked as the Chief Executive Officer at Celonic AG and as the SEVP-Business Development & Operations at AYOXXA Biosystems GmbH.
He holds a doctorate degree from Universität Konstanz.
Actieve functies van Konstantin Matentzoglu
| Bedrijven | Functie | Begin |
|---|---|---|
| Polpharma Biologics Group BV | Directeur/Bestuurslid | - |
Eerdere bekende functies van Konstantin Matentzoglu
| Bedrijven | Functie | Einde |
|---|---|---|
Celonic AG
 Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Algemeen Directeur | - |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Operationeel Directeur | - |
Opleiding van Konstantin Matentzoglu
| Universität Konstanz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Celonic AG
Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Health Technology |
| Polpharma Biologics Group BV |
